Company Filing History:
Years Active: 2016-2024
Title: Innovations by Jennifer Anne McMahon
Introduction
Jennifer Anne McMahon is a prominent inventor based in Zionsville, Indiana. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective estrogen receptor degraders. With a total of five patents to her name, McMahon's work is recognized for its potential impact on medical treatments.
Latest Patents
Among her latest patents are novel selective estrogen receptor degraders (SERDs). These innovations include formulations that consist of pharmaceutically acceptable salts and pharmaceutical compositions. The compounds are characterized by specific chemical structures, where either R or R' is independently selected from Cl, F, —CF, or —CH, while the other is hydrogen. Methods for their use are also provided, showcasing the versatility and applicability of her inventions.
Career Highlights
Jennifer McMahon is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. Her role at the company allows her to leverage her expertise in drug development and innovation. Throughout her career, she has focused on creating solutions that address critical health issues.
Collaborations
Some of her notable coworkers include Jolie Anne Bastian and Jeffrey Daniel Cohen. Their collaborative efforts contribute to the advancement of research and development within the company.
Conclusion
Jennifer Anne McMahon's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments.